Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126255041 | 12625504 | 1 | I | 20160721 | 20160805 | 20160805 | EXP | AU-CELGENEUS-AUS-2016075302 | CELGENE | 0.00 | Y | 0.00000 | 20160805 | MD | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126255041 | 12625504 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 10 | MG | CAPSULES | QD | |||||
126255041 | 12625504 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 15 | MG | CAPSULES | QD | |||||
126255041 | 12625504 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 250 MILLIGRAM | U | U | 0 | 500 | MG | UNKNOWN | QOD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126255041 | 12625504 | 1 | Plasma cell myeloma |
126255041 | 12625504 | 3 | Plasma cell myeloma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126255041 | 12625504 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126255041 | 12625504 | Acute myeloid leukaemia | |
126255041 | 12625504 | Anaemia | |
126255041 | 12625504 | Bone marrow failure | |
126255041 | 12625504 | Diarrhoea | |
126255041 | 12625504 | Fatigue | |
126255041 | 12625504 | Gastrointestinal carcinoma | |
126255041 | 12625504 | Hyperglycaemia | |
126255041 | 12625504 | Insomnia | |
126255041 | 12625504 | Lower respiratory tract infection | |
126255041 | 12625504 | Muscle spasms | |
126255041 | 12625504 | Neuropathy peripheral | |
126255041 | 12625504 | Neutropenia | |
126255041 | 12625504 | Retinal vein thrombosis | |
126255041 | 12625504 | Skin cancer | |
126255041 | 12625504 | Thrombocytopenia | |
126255041 | 12625504 | Upper respiratory tract infection | |
126255041 | 12625504 | Varicella zoster virus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |